| Variable | No | Median, months ( range) |
| Gender Male Female †Symptomatic at presentation, n. (%) Yes No Local recurrence Yes No Metastatic status Yes Synchronic Metachronic No Number of metastases Solitary Multiple †Regional nodal involvement: Yes No Major vein extension: Present Absent †Surgical margin, n. (%): Negative Positive Lymphadenectomy Yes No Chemotherapy Yes No Targeted Therapy Yes No |
16 8
11 5
6 18
19 13 6 5
7 12
14 6
10 14
11 9
15 9
14 10
5 19 |
9.2 (3.2 - 40.0) 14.2 (1.2 - 52.0)
14.4 (1.2 - 35.4) 6.8 (4.8 - 52.0)
25.8 (14.4 - 52.0) 8.3 (1.2 - 35.4)
14.2 (3.5 - 52.0) 9.5 (3.5 - 52.0) 24.4 (13.3 - 40.0) 4.8 (1.2 - 12.4)
15.0 (5.5 - 40.0) 13.8 (3.5 - 52.0)
9.1 (3.2 - 26.5) 19.8 (5.5 - 40.0)
8.3 (1.2 - 23.6) 13.8 (4.8 - 52.0)
14.2 (4.8 - 52.0) 8.7 (1.2 - 25.2)
10.2 (3.2 - 40.0) 14.4 (1.2 - 52.0)
14.7 (3.5 - 52.0) 6.1 (1.2 - 26.5)
14.2 (5.8 - 26.5) 10.2 (1.2 - 52.0) |